Psykey, Inc. (OTCMKTS:CEOS) Sees Significant Decline in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 2,400 shares, a decline of 60.1% from the November 30th total of 6,013 shares. Based on an average daily trading volume, of 147,973 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 147,973 shares, the days-to-cover ratio is presently 0.0 days.

Psykey Stock Up 3.6%

OTCMKTS CEOS opened at $0.00 on Friday. Psykey has a 12 month low of $0.00 and a 12 month high of $0.04.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.